<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Gbs Guillain Barre Syndrome • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Gbs Guillain Barre Syndrome • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/gbs guillain barre syndrome/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/gbs guillain barre syndrome/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="gbs" tabindex="-1">GBS</h1>
<ul>
<li>related: <a href="/wiki/notes/Neurology/">Neurology</a></li>
<li>tags: #neuro</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220805090853.png" alt="">
Classic GBS presents as a progressive, symmetric <strong>ascending</strong> weakness or paralysis, often a few days to a week after a respiratory or gastrointestinal infection (especially <em>Campylobacter jejuni</em>).  About one-third of patients have <mark>no history of antecedent illness</mark>.  As the weakness ascends (eg, difficulty walking with 3/5 strength in the lower extremities compared with 4/5 strength in the upper extremities in this patient), <strong>==bulbar</strong> symptoms== (eg, ophthalmoplegia, facial diplegia, <strong>dysarthria</strong>, dysphasia) and <mark>respiratory compromise</mark> can develop.  <strong><mark>Back pain</mark></strong> can be a presenting feature of GBS as the disease targets primarily the proximal nerves and nerve roots in either the cervical or lumbar spine.  Although GBS is primarily a motor polyneuropathy, patients can have <mark>mild sensory symptoms</mark> such as paresthesias and sensory ataxia.  GBS patients also are at risk of developing <mark>dysautonomia</mark> (eg, tachycardia, diaphoresis, <strong>sluggish pupils</strong>).  Examination shows <strong><mark>absent reflexes</mark></strong>.</p>
<p><strong><mark>Lumbar puncture</mark></strong> is indicated in all suspected GBS patients to rule out infectious etiologies and document elevated cerebrospinal protein with a normal cerebrospinal fluid white blood cell count <strong>(albuminocytologic dissociation)</strong>.  However, lumbar puncture may not be diagnostic in some GBS patients as it may take up to a week after symptom onset to see the abnormal findings.  Nerve conduction study and electromyography are also indicated to confirm the diagnosis and estimate prognosis.</p>
<p>Treatment is mainly supportive, with <strong>plasma exchange or intravenous immunoglobulin</strong>.  Current evidence does <strong>not</strong> recommend corticosteroids as they are not beneficial.  Most patients recover within several weeks to months.</p>
<!-- GBS respiratory management, prognosis -->
<ul>
<li>high risk of respiratory failure: frequent measure <strong>vital capacity</strong> and <strong>negative inspiratory force</strong></li>
<li><strong>plasma exchange</strong> or <strong>IVIG</strong> to combat antibodies against nerves</li>
<li>Patients with GBS should receive plasma exchange or IVIG if:
<ul>
<li><strong>Nonambulatory</strong></li>
<li><strong>Within 4 weeks of symptom onset</strong></li>
</ul>
</li>
<li>Those who are ambulatory and recovering generally do not require treatment.</li>
<li>Transverse myelitis is typically treated with high-dose glucocorticoids, not GBS</li>
</ul>
<p>The manifestations of <strong>Guillain-Barré syndrome</strong> (GBS) tend to evolve as follows:</p>
<ul>
<li>2 weeks of progressive motor weakness that can lead to paralysis</li>
<li>2-4 weeks of plateaued symptoms</li>
<li><strong>Slow, spontaneous recovery over months</strong></li>
</ul>
<p>At a year after symptom onset, 85% of patients with GBS have regained the ability to walk and nearly 60% have had full, spontaneous neurologic recovery.  Although patients with GBS typically recover without intervention, treatment with plasma exchange or intravenous immunoglobulin <strong>shortens the time to recovery</strong> by approximately 50%.</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Neurology/" class="peer">Neurology</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="neurology" tabindex="-1">Neurology</h1>
<ul>
<li>related: <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<ul>
<li><a href="/wiki/notes/Headache%20and%20Facial%20Pain/">Headache and Facial Pain</a></li>
<li><a href="/wiki/notes/Head%20Injury/">Head Injury</a></li>
<li><a href="/wiki/notes/Seizures%20and%20Epilepsy/">Seizures and Epilepsy</a></li>
<li><a href="/wiki/notes/Stroke/">Stroke</a></li>
<li><a href="/wiki/notes/Cognitive%20Impairment/">Cognitive Impairment</a></li>
<li><a href="/wiki/notes/Movement%20Disorders/">Movement Disorders</a></li>
<li><a href="/wiki/notes/Multiple%20Sclerosis/">Multiple Sclerosis</a></li>
<li><a href="/wiki/notes/Disorders%20of%20Spinal%20Cord/">Disorders of Spinal Cord</a></li>
<li><a href="/wiki/notes/Neuromuscular%20Disorders/">Neuromuscular Disorders</a></li>
<li><a href="/wiki/notes/Neuro%20Oncology/">Neuro Oncology</a></li>
</ul>
<h2 id="meningitis" tabindex="-1">Meningitis</h2>
<ul>
<li><a href="/wiki/notes/lumbar%20puncture/">lumbar puncture</a></li>
<li><a href="/wiki/notes/meningitis/">meningitis</a></li>
<li><a href="/wiki/notes/encephalopathy/">encephalopathy</a></li>
</ul>
<h2 id="myopathy" tabindex="-1">Myopathy</h2>
<ul>
<li><a href="/wiki/notes/myopathy%20ddx/">myopathy ddx</a></li>
<li><a href="/wiki/notes/movement%20disorders%202/">movement disorders 2</a></li>
<li><a href="/wiki/notes/transverse%20mylelitis/">transverse mylelitis</a></li>
<li>[[gbs guillai</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
